LIFE - aTyr Pharma GAAP EPS of -$0.26 beats by $0.22 revenue of $10.4M beats by $10.15M
2023-03-09 16:02:57 ET
- aTyr Pharma press release ( NASDAQ: LIFE ): Q4 GAAP EPS of -$0.26 beats by $0.22 .
- Revenue of $10.4M beats by $10.15M .
- Based on the company’s current operational plans and existing cash, LIFE believes the company’s cash runway will extend into 2026.
For further details see:
aTyr Pharma GAAP EPS of -$0.26 beats by $0.22, revenue of $10.4M beats by $10.15M